slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 75,331-75,360
Pages 3,679
Rows per page 30
Component
75,331-75,360 of 110,355
02
Absci | Investor Presentation Deck | 42 slidesAbsci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations 1 hit
06
The slide uses a process flow diagram to contrast traditional/public data with the high-volume output of the ACE Assay.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
25
The slide uses a process flow (1: Data generation, 2: Model training) followed by validation results (scatter plot and correlation table).Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
29
The slide uses a histogram to visualize the distribution of binding affinity (-log10(Kd)) for designed variants versus the wild-type baseline.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
33
Includes a Kaplan-Meier survival curve as evidence for the clinical relevance of TLS.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations 1 hit
06
The slide outlines a clinical trial protocol using a process flow diagram.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations 1 hit
04
Uses a two-column comparison for Sepsis vs Septic Shock, followed by two rows of key metrics.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a process flow diagram to contrast time-to-diagnosis and a bar chart to illustrate the exponential mortality risk of delayed treatment.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a problem-solution framing, identifying the biomarker's potential and the specific pain point (time-sensitivity) that the Symphony IL-6 assay solves.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
The slide highlights the superior NPV of IL-6 compared to standard biomarkers using a table and an ROC curve.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
The slide uses a bottom-up market sizing approach based on patient volumes and testing frequency.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · Market SizingLoop · Quick Win Big Bet1 hit
14
The table compares 7 distinct operational metrics between the Bluejay Symphony and competitors (Beckman, Siemens, Roche).Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
05
The slide uses a hub-and-spoke visual structure to categorize benefits by stakeholder group.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
06
Includes a callout highlighting J&J's Darzalex Faspro achieving 85% conversion in under 2 years.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
08
The slide features a screenshot of a specific scientific paper as evidence of peer-reviewed validation.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
09
The slide highlights a 77% viscosity reduction for Infliximab and a 45-78% reduction for Ipilimumab.Comera | Investor Presentation Deck | 16 slides · Comera
Pitch deck Investor relations Beat · Evidence & ProofLoop · Golden Circle1 hit
05
The chart uses a stacked area visualization to show cumulative growth across different industry verticals.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
09
The slide uses a mix of bulleted statistics and circular callouts for key metrics.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · InterestLoop · Logic Chain1 hit
11
The visual uses a hub-and-spoke style diagram with interconnected circular nodes representing the three focus areas.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Desire1 hit
23
The slide uses a scientific publication as social proof and a log-log chart to demonstrate performance scaling.D-Wave | Investor Presentation Deck | 28 slides · D-Wave
Pitch deck Investor relations Beat · Action1 hit
14
The slide uses a hub-and-spoke diagram to illustrate how various financial metrics contribute to 'Strategic Flexibility'.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
19
The slide details a dual-class share structure with 196M total shares outstanding.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations 1 hit
21
2020 data omitted due to pandemic distortion.Vivid Seats | Results Presentation Deck | 22 slides · Vivid Seats
Conference presentation Investor relations 1 hit
04
Includes a footnote regarding the date of the cash position.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · AttentionLoop · Hypothesis Test1 hit
05
Data sourced from China National Bureau of Statistics (CNBS).Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
The slide highlights a shift in revenue mix towards skincare brands despite a slight YoY decline in absolute revenue.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
1 DR.WU's mainland China businessYatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
Slide 11 of a presentation deck.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · Action1 hit
12
The chart shows a 3.8 percentage point YoY increase in total operating expenses.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · Action1 hit
13
The slide provides a detailed breakdown of adjustments made to GAAP figures to arrive at non-GAAP metrics.Yatsen | Results Presentation Deck | 15 slides · Yatsen
Conference presentation Investor relations Beat · Action1 hit